FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020334178> ?p ?o ?g. }

• W2020334178 endingPage "209" @default.
• W2020334178 startingPage "209" @default.
• W2020334178 abstract "In cystic fibrosis (CF), the paranasal sinuses are sites of first and persistent colonization by pathogens such as Pseudomonas aeruginosa. Pathogens subsequently descend to the lower airways, with P. aeruginosa remaining the primary cause of premature death in patients with the inherited disease. Unlike conventional aerosols, vibrating aerosols applied with the PARI Sinus™ nebulizer deposit drugs into the paranasal sinuses. This trial assessed the effects of vibrating sinonasal inhalation of the antibiotic tobramycin in CF patients positive for P. aeruginosa in nasal lavage.To evaluate the effects of sinonasal inhalation of tobramycin on P. aeruginosa quantification in nasal lavage; and on patient quality of life, measured with the Sino-Nasal Outcome Test (SNOT-20), and otologic and renal safety and tolerability.Patients were randomized to inhalation of tobramycin (80 mg/2 mL) or placebo (2 mL isotonic saline) once daily (4 minutes/nostril) with the PARI Sinus™ nebulizer over 28 days, with all patients eligible for a subsequent course of open-label inhalation of tobramycin for 28 days. Nasal lavage was obtained before starting and 2 days after the end of each treatment period by rinsing each nostril with 10 mL of isotonic saline.Nine patients participated, six initially receiving tobramycin and three placebo. Sinonasal inhalation was well tolerated, with serum tobramycin <0.5 mg/L and stable creatinine. P. aeruginosa quantity decreased in four of six (67%) patients given tobramycin, compared with zero of three given placebo (non-significant). SNOT-20 scores were significantly lower in the tobramycin than in the placebo group (P=0.033).Sinonasal inhalation of vibrating antibiotic aerosols appears promising for reducing pathogen colonization of paranasal sinuses and for control of symptoms in patients with CF." @default.
• W2020334178 created "2016-06-24" @default.
• W2020334178 creator A5000547026 @default.
• W2020334178 creator A5001589967 @default.
• W2020334178 creator A5010612832 @default.
• W2020334178 creator A5026961718 @default.
• W2020334178 creator A5028888231 @default.
• W2020334178 creator A5030440126 @default.
• W2020334178 creator A5055154765 @default.
• W2020334178 creator A5056417520 @default.
• W2020334178 creator A5064260275 @default.
• W2020334178 creator A5064549207 @default.
• W2020334178 creator A5091281566 @default.
• W2020334178 date "2014-02-01" @default.
• W2020334178 modified "2023-09-26" @default.
• W2020334178 title "Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study" @default.
• W2020334178 cites W1498107417 @default.
• W2020334178 cites W1978294758 @default.
• W2020334178 cites W1981642035 @default.
• W2020334178 cites W2008767096 @default.
• W2020334178 cites W2028502510 @default.
• W2020334178 cites W2029488580 @default.
• W2020334178 cites W2037386090 @default.
• W2020334178 cites W2067296019 @default.
• W2020334178 cites W2071665252 @default.
• W2020334178 cites W2072741628 @default.
• W2020334178 cites W2074621292 @default.
• W2020334178 cites W2081226232 @default.
• W2020334178 cites W2081548537 @default.
• W2020334178 cites W2086235445 @default.
• W2020334178 cites W2089559025 @default.
• W2020334178 cites W2092505971 @default.
• W2020334178 cites W2094866624 @default.
• W2020334178 cites W2114074118 @default.
• W2020334178 cites W2114494355 @default.
• W2020334178 cites W2119986491 @default.
• W2020334178 cites W2153927784 @default.
• W2020334178 cites W2155069031 @default.
• W2020334178 cites W2155094676 @default.
• W2020334178 cites W2161010089 @default.
• W2020334178 cites W2326999967 @default.
• W2020334178 cites W2411051113 @default.
• W2020334178 cites W3149115522 @default.
• W2020334178 cites W54532001 @default.
• W2020334178 doi "https://doi.org/10.2147/dddt.s54064" @default.
• W2020334178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3930477" @default.
• W2020334178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24596456" @default.
• W2020334178 hasPublicationYear "2014" @default.
• W2020334178 type Work @default.
• W2020334178 sameAs 2020334178 @default.
• W2020334178 citedByCount "64" @default.
• W2020334178 countsByYear W20203341782014 @default.
• W2020334178 countsByYear W20203341782015 @default.
• W2020334178 countsByYear W20203341782016 @default.
• W2020334178 countsByYear W20203341782017 @default.
• W2020334178 countsByYear W20203341782018 @default.
• W2020334178 countsByYear W20203341782019 @default.
• W2020334178 countsByYear W20203341782020 @default.
• W2020334178 countsByYear W20203341782021 @default.
• W2020334178 countsByYear W20203341782022 @default.
• W2020334178 countsByYear W20203341782023 @default.
• W2020334178 crossrefType "journal-article" @default.
• W2020334178 hasAuthorship W2020334178A5000547026 @default.
• W2020334178 hasAuthorship W2020334178A5001589967 @default.
• W2020334178 hasAuthorship W2020334178A5010612832 @default.
• W2020334178 hasAuthorship W2020334178A5026961718 @default.
• W2020334178 hasAuthorship W2020334178A5028888231 @default.
• W2020334178 hasAuthorship W2020334178A5030440126 @default.
• W2020334178 hasAuthorship W2020334178A5055154765 @default.
• W2020334178 hasAuthorship W2020334178A5056417520 @default.
• W2020334178 hasAuthorship W2020334178A5064260275 @default.
• W2020334178 hasAuthorship W2020334178A5064549207 @default.
• W2020334178 hasAuthorship W2020334178A5091281566 @default.
• W2020334178 hasBestOaLocation W20203341781 @default.
• W2020334178 hasConcept C126322002 @default.
• W2020334178 hasConcept C141071460 @default.
• W2020334178 hasConcept C142724271 @default.
• W2020334178 hasConcept C197934379 @default.
• W2020334178 hasConcept C204787440 @default.
• W2020334178 hasConcept C27081682 @default.
• W2020334178 hasConcept C2776938444 @default.
• W2020334178 hasConcept C2776954882 @default.
• W2020334178 hasConcept C2777637488 @default.
• W2020334178 hasConcept C2777768476 @default.
• W2020334178 hasConcept C2778311950 @default.
• W2020334178 hasConcept C2778375690 @default.
• W2020334178 hasConcept C2778974779 @default.
• W2020334178 hasConcept C2779789940 @default.
• W2020334178 hasConcept C2909814679 @default.
• W2020334178 hasConcept C42219234 @default.
• W2020334178 hasConcept C523546767 @default.
• W2020334178 hasConcept C54355233 @default.
• W2020334178 hasConcept C71924100 @default.
• W2020334178 hasConcept C86803240 @default.
• W2020334178 hasConceptScore W2020334178C126322002 @default.
• W2020334178 hasConceptScore W2020334178C141071460 @default.
• W2020334178 hasConceptScore W2020334178C142724271 @default.
• W2020334178 hasConceptScore W2020334178C197934379 @default.

• next